Apogee Therapeutics (APGE) SEC Filings & 10K Form

$47.25

-0.99 (-2.05%)

(As of 09/6/2024 ET)

Compare

Recent Apogee Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
09/06/2024 7:02 PM	Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/06/2024 7:03 PM	Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/04/2024 12:35 PM	Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
08/23/2024 7:05 PM	Apogee Therapeutics (Issuer) Henderson Jane (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/19/2024 6:29 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/12/2024 4:25 PM	Apogee Therapeutics (Filer)	Form S-3ASR
08/12/2024 6:00 AM	Apogee Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
Get the Latest News and Ratings for APGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apogee Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
08/12/2024 5:35 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/09/2024 7:05 PM	Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/09/2024 7:05 PM	Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/07/2024 12:18 PM	Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
07/05/2024 7:01 PM	Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2024 7:01 PM	Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
07/05/2024 12:39 PM	Apogee Therapeutics (Subject) HENDERSON MICHAEL THOMAS (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
07/03/2024 12:13 PM	Apogee Therapeutics (Subject) Dambkowski Carl (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
06/07/2024 7:12 PM	Apogee Therapeutics (Issuer) JONES WILLIAM A JR (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:00 PM	Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:01 PM	Apogee Therapeutics (Issuer) Gottesdiener Andrew (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:02 PM	Apogee Therapeutics (Issuer) Shah Nimish P (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:03 PM	Apogee Therapeutics (Issuer) Fox Jennifer A. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:04 PM	Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/07/2024 7:05 PM	Apogee Therapeutics (Issuer) McKenna Mark C. (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/30/2024 7:05 PM	Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)	Form 3 Initial statement of beneficial ownership of securities
05/30/2024 7:07 PM	Apogee Therapeutics (Issuer) Bollinger Lisa (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
05/28/2024 6:35 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/28/2024 6:36 AM	Apogee Therapeutics (Filer)	Form DEFA14A
05/15/2024 3:39 PM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/13/2024 6:10 AM	Apogee Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/13/2024 6:26 AM	Apogee Therapeutics (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
05/13/2024 6:05 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/24/2024 3:15 PM	Apogee Therapeutics (Filer)	Form DEF 14A
04/24/2024 3:16 PM	Apogee Therapeutics (Filer)	Form DEFA14A
04/24/2024 3:18 PM	Apogee Therapeutics (Filer)	Form ARS
04/01/2024 4:42 PM	Apogee Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)	Form SC 13D/A
04/01/2024 4:44 PM	Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
03/25/2024 6:30 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/11/2024 5:01 AM	Apogee Therapeutics (Filer)	Form 424B4
03/07/2024 11:15 PM	Apogee Therapeutics (Filer)	Form EFFECT
03/07/2024 5:27 PM	Apogee Therapeutics (Filer)	Form S-1MEF
03/05/2024 7:15 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/05/2024 5:11 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can.
03/05/2024 5:15 AM	Apogee Therapeutics (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
02/14/2024 7:35 AM	Apogee Therapeutics (Subject) Deep Track Capital, LP (Filed by)	Form SC 13G/A
02/09/2024 7:35 AM	Apogee Therapeutics (Subject) FMR LLC (Filed by)	Form SC 13G/A
01/31/2024 3:30 PM	Apogee Therapeutics (Subject) Fairmount Funds Management LLC (Filed by)	Form SC 13D/A
01/31/2024 3:31 PM	Apogee Therapeutics (Issuer) Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Co-Invest II L.P. (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Harwin Peter Evan (Reporting) Kiselak Tomas (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/20/2023 7:00 PM	Apogee Therapeutics (Issuer) HENDERSON MICHAEL THOMAS (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/20/2023 7:00 PM	Apogee Therapeutics (Issuer) Henderson Jane (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/20/2023 7:01 PM	Apogee Therapeutics (Issuer) Dambkowski Carl (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
11/13/2023 6:41 AM	Apogee Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/13/2023 6:45 AM	Apogee Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)